Doughertys Pharmacy Buy Hold or Sell Recommendation

    ASDS -- USA Stock  

    USD 0.17  0.00  0.00%

    Given the investment horizon of 30 days, and your above average risk tolerance our recommendation regarding Doughertys Pharmacy is 'Not Rated'. Macroaxis provides Doughertys Pharmacy buy hold or sell recommendation only in the context of selected investment horizon and investor attitude towards risk assumed by holding ASDS positions. The advice algorithm takes into account all of Doughertys Pharmacy available fundamental, technical, and predictive indicators you will find on this site. The advice is provided from ASDS buy-and-hold prospective. Check also Trending Equities.

    Time Horizon

    Risk Tolerance

    Symbol
    Execute Advice
    Sell Doughertys PharmacyBuy Doughertys Pharmacy
    Not Rated
    For the selected time horizon Doughertys Pharmacy has a risk adjusted performance of 0.0, jensen alpha of 0.0, total risk alpha of 0.0, sortino ratio of 0.0 and treynor ratio of 0.0
    We provide buy or sell advice to complement the prevailing expert consensus on Doughertys Pharmacy. Our dynamic recommendation engine makes use of multi - dimensional algorithm to analyze the company potential to grow using all technical and fundamental data available at the time. To make sure Doughertys Pharmacy is not overpriced, please confirm all Doughertys Pharmacy fundamentals including its Net Income and the relationship between Current Ratio and Current Asset . As Doughertys Pharmacy appears to be a penny stock we also advise to verify its Price to Book numbers.
       Exercise or conversion by Anthony LeVecchio of 5250 shares of Doughertys Pharmacy subject to Rule 16b-3 [view details]

    Doughertys Pharmacy Alerts

    Trading Alerts and Improvement Suggestions

    Doughertys Pharmacy is not yet fully synchronised with the market data
    Doughertys Pharmacy generates negative expected return over the last 30 days
    Doughertys Pharmacy has some characteristics of a very speculative penny stock
    Doughertys Pharmacy has high likelihood to experience some financial distress in the next 2 years
    Doughertys Pharmacy has high financial leverage indicating that it may have difficulties to generate enough cash to satisfy its financial obligations
    The company reported previous year revenue of 42.02 M. Net Loss for the year was (4.81 M) with profit before overhead, payroll, taxes, and interest of 11.05 M.
    Check also Trending Equities. Please also try Headlines Timeline module to stay connected to all market stories and filter out noise. drill down to analyze hype elasticity.
    Search macroaxis.com